Melanoma vax shows early promise; H7N9 deadlier than earlier outbreaks;

> A melanoma vaccine made up of dendritic cells has shown promise in a 12-person trial. Item

> A paper in The Lancet reports H7N9 is deadlier than both H5N1 and H1N1. Research

> Non-profit Sabin Vaccine Institute has formed the International Association of Immunization Managers. Release

> The CDC estimates influenza vaccines have prevented 13.6 million cases of flu over the past 6 years. News

> Researchers have used gold nanorods to deliver proteins to immune cells. Piece

> A vaccine shortage is hindering efforts to control a measles outbreak that has killed 500 children in Pakistan. Article

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.